PHARMACIERGE_LIMITED - Accounts

Company Registration No. 09524408 (England and Wales)
PHARMACIERGE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017
PAGES FOR FILING WITH REGISTRAR
PHARMACIERGE LIMITED
COMPANY INFORMATION
Directors
Mr E G Ungar
(Appointed 1 October 2016)
Mr L A Ungar
Mr R D L Ungar
(Appointed 1 October 2016)
Secretary
Mr R D L Ungar
Company number
09524408
Registered office
3rd Floor Hathaway House
Popes Drive
London
N3 1QF
Accountants
F M C B
3rd Floor Hathaway House
Popes Drive
Finchley
London
N3 1QF
Business address
9 Candover Street
London
W1W 7DN
Bankers
HSBC Bank plc
Lion House
25 Islington High Street
London
N1 9LJ
PHARMACIERGE LIMITED
BALANCE SHEET
AS AT 30 SEPTEMBER 2017
30 September 2017
- 1 -
2017
2016
Notes
£
£
£
£
Fixed assets
Goodwill
3
59,600
67,050
Tangible assets
4
14,956
400
74,556
67,450
Current assets
Stocks
48,345
30,000
Debtors
5
205,498
139,954
Cash at bank and in hand
163,481
158,650
417,324
328,604
Creditors: amounts falling due within one year
6
(287,996)
(311,123)
Net current assets
129,328
17,481
Total assets less current liabilities
203,884
84,931
Creditors: amounts falling due after more than one year
7
(81,933)
(81,933)
Net assets
121,951
2,998
Capital and reserves
Called up share capital
8
1
1
Profit and loss reserves
121,950
2,997
Total equity
121,951
2,998

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial Year ended 30 September 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the Year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

PHARMACIERGE LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2017
30 September 2017
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 28 June 2018 and are signed on its behalf by:
Mr L A Ungar
Director
Company Registration No. 09524408
PHARMACIERGE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017
- 3 -
1
Accounting policies
Company information

Pharmacierge Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3rd Floor Hathaway House, Popes Drive, Finchley, London, N3 1QF.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

These financial statements for the Year ended 30 September 2017 are the first financial statements of Pharmacierge Limited prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 2 April 2015. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes

Revenue from the sale of goods is recognized when goods are delivered and legal title has passed. Revenue from the provision of services is recognised when those services have been performed.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
20% Straight Line
Computer equipment
20% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

PHARMACIERGE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2017
1
Accounting policies
(Continued)
- 4 -
1.6
Impairment of fixed assets

At each reporting date fixed assets are reviewed to determine whether there is any indication that those assets have suffered a material impairment loss. If a material impairment loss arises then it is recognised in the profit and loss account or against the revaluation reserve if the asset has been revalued.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

1.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

PHARMACIERGE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2017
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the Year was 10 (2016 - 7).

3
Intangible fixed assets
Goodwill
£
Cost
At 1 October 2016 and 30 September 2017
74,500
Amortisation and impairment
At 1 October 2016
7,450
Amortisation charged for the Year
7,450
At 30 September 2017
14,900
Carrying amount
At 30 September 2017
59,600
At 30 September 2016
67,050

The business and assets of Independent Dispensary Limited, an insolvent company, were acquired by Pharmacierge Limited on 8 September 2015. They were professionally valued by Ashwells Nationwide Services Limited, who valued the tangible assets and goodwill of the company at £75,000. The split of goodwill has been determined by the directors at £74,500.

4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 October 2016
500
Additions
18,295
At 30 September 2017
18,795
Depreciation and impairment
At 1 October 2016
100
Depreciation charged in the Year
3,739
At 30 September 2017
3,839
Carrying amount
At 30 September 2017
14,956
At 30 September 2016
400
PHARMACIERGE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2017
- 6 -
5
Debtors
2017
2016
Amounts falling due within one year:
£
£
Trade debtors
21,276
29,765
Amounts due from group undertakings
149,031
77,500
Other debtors
35,191
32,689
205,498
139,954
6
Creditors: amounts falling due within one year
2017
2016
£
£
Trade creditors
264,947
265,079
Amounts due to group undertakings
-
16,520
Corporation tax
1,878
4,527
Other taxation and social security
11,276
5,722
Other creditors
9,895
19,275
287,996
311,123
7
Creditors: amounts falling due after more than one year
2017
2016
£
£
Other creditors
81,933
81,933
8
Called up share capital
2017
2016
£
£
Ordinary share capital
Issued and fully paid
1 Ordinary share of £1 each
1
1
PHARMACIERGE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2017
- 7 -
9
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts advanced
Closing balance
£
£
£
Mr L A Ungar - Director's current account
-
-
310
310
-
310
310
10
Parent company

The company is a wholly owned subsidiary of Pharmacierge Group Limited, a company registered in England and Wales and its registered office is 3rd Floor Hathaway House, Popes Drive, London, N3 1QF.

The ultimate controlling party is Pharmacierge Group Limited.

2017-09-302016-10-01falseCCH SoftwareCCH Accounts Production 2018.100No description of principal activity29 June 2018Mr L A UngarMr R D L UngarMr E G UngarMr R D L Ungar095244082016-10-012017-09-3009524408bus:Director12016-10-012017-09-3009524408bus:Director22016-10-012017-09-3009524408bus:CompanySecretaryDirector12016-10-012017-09-3009524408bus:CompanySecretary12016-10-012017-09-3009524408bus:Director32016-10-012017-09-3009524408bus:RegisteredOffice2016-10-012017-09-3009524408bus:Agent12016-10-012017-09-30095244082017-09-3009524408core:Goodwill2017-09-3009524408core:Goodwill2016-09-3009524408core:NetGoodwill2017-09-3009524408core:NetGoodwill2016-09-30095244082016-09-3009524408core:OtherPropertyPlantEquipment2017-09-3009524408core:OtherPropertyPlantEquipment2016-09-3009524408core:CurrentFinancialInstruments2017-09-3009524408core:CurrentFinancialInstruments2016-09-3009524408core:Non-currentFinancialInstruments2017-09-3009524408core:Non-currentFinancialInstruments2016-09-3009524408core:ShareCapital2017-09-3009524408core:ShareCapital2016-09-3009524408core:RetainedEarningsAccumulatedLosses2017-09-3009524408core:RetainedEarningsAccumulatedLosses2016-09-3009524408core:Goodwill2016-10-012017-09-3009524408core:FurnitureFittings2016-10-012017-09-3009524408core:ComputerEquipment2016-10-012017-09-3009524408core:NetGoodwill2016-09-3009524408core:NetGoodwill2016-10-012017-09-3009524408core:OtherPropertyPlantEquipment2016-09-3009524408core:OtherPropertyPlantEquipment2016-10-012017-09-3009524408bus:PrivateLimitedCompanyLtd2016-10-012017-09-3009524408bus:FRS1022016-10-012017-09-3009524408bus:AuditExemptWithAccountantsReport2016-10-012017-09-3009524408bus:SmallCompaniesRegimeForAccounts2016-10-012017-09-3009524408bus:FullAccounts2016-10-012017-09-30xbrli:purexbrli:sharesiso4217:GBP